Milestone Pharmaceuticals Inc

MIST

Company Profile

  • Business description

    Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

  • Contact

    1111 Dr. Frederik-Philips Boulevard
    Suite 420
    MontrealQCH4M 2X6
    CAN

    T: +1 514 336-0444

    https://www.milestonepharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    33

Stocks News & Analysis

stocks

Are declining Chinese births a red flag for A2 Milk?

Demographic challenges in A2’s largest market lead to sell-off.
stocks

Is this ASX share a value trap or bargain?

Cost-cutting the priority as underlying asset values falling on deaf ears.
stocks

Goldman Sachs Earnings: Valuations remain stretched

We raise our fair value estimate for Goldman Sachs stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,108.6016.200.18%
CAC 408,055.347.24-0.09%
DAX 4024,468.82234.30-0.95%
Dow JONES (US)48,488.59870.74-1.76%
FTSE 10010,131.644.860.05%
HKSE26,585.0697.550.37%
NASDAQ22,954.32561.07-2.39%
Nikkei 22552,774.64216.46-0.41%
NZX 50 Index13,417.17156.76-1.15%
S&P 5006,796.860.000.00%
S&P/ASX 2008,782.9014.000.16%
SSE Composite Index4,116.943.290.08%

Market Movers